Status:
COMPLETED
Cannabidiol and Autonomic Function at Rest
Lead Sponsor:
Castleton University
Conditions:
Healthy
Eligibility:
All Genders
18-35 years
Phase:
EARLY_PHASE1
Brief Summary
Cannabidiol (CBD) is one of 700 chemicals derived from the Cannabis sativa plant and is both legal and widespread for distribution in the state of Vermont. The central hypothesis of this proposal is t...
Detailed Description
The study will be conducted in the Exercise Physiology Laboratory in the Jeffords Science Building at Castleton University. Participants will be asked to fast overnight, avoid beverages or food contai...
Eligibility Criteria
Inclusion
- Male or female, 18-35 years of age.
- Participants must agree to fast and abstain from food or beverages containing alcohol, caffeine, or CBD for 12 hours prior to each experimental session.
- Completion of Health History Questionnaire with report indicating overall good health.
- The ability to comprehend and satisfactorily comply with protocol requirements.
- Written informed consent given prior to beginning the study.
Exclusion
- Current medications that might influence the cardiovascular and/or autonomic systems.
- Women who are pregnant or lactating.
- Participants who have a history of adverse reactions to cannabidiol will be excluded.
Key Trial Info
Start Date :
August 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 29 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04731779
Start Date
August 30 2021
End Date
November 29 2021
Last Update
May 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Castleton University, Jeffords Science Building
Castleton, Vermont, United States, 05735